Iran-born Biotech Investor Aims to Cure 'Two Cancers'

An Iran-born Nasdaq biotech investor, Amir Heshmatpour, discusses his efforts to cure brain cancer and expresses support for ending Iran's clerical rule, metaphorically referring to 'two cancers'.

3 Mar, 14:28 — 3 Mar, 14:28

Post Share

ℹOnly 1 source covers this story

Read at source (1 outlet)

jerusalem-post2h ago

Iran-born anti-regime Nasdaq biotech investor says he is trying to cure ‘two cancers’ - interview

Iran-born US biotech CEO Amir Heshmatpour says his Nasdaq-listed brain cancer company will begin treating patients in Israel within weeks, as he also voices support for ending Iran’s clerical rule.

Read full article →

PERSPECTA

PERSPECTA

Iran-born Biotech Investor Aims to Cure 'Two Cancers'

Read at source (1 outlet)

Iran-born anti-regime Nasdaq biotech investor says he is trying to cure ‘two cancers’ - interview

Related Stories

Middle East could lose up to $56 billion in tourism revenue as US-Israeli war on Iran takes toll

Portuguese Government Offers Support to Micro-Enterprises

UK Crypto Exchanges Accused of Moving $1 Billion for IRGC

Hungary Admits Delays in Budapest-Belgrade Railway Project

PERSPECTA